Tenfold increased incidence of spontaneous multiple myeloma in long-term immunosuppressed aging C57BL/KaLwRij mice

Clinical Immunology and Immunopathology

Volumn 79, Issue 2, 1996, Pages 155-162

  Radl, Jiri ^a   Van Arkel, Cornelis ^a,b   Hopstaken, Cornelis M ^a   Hogenesch, Harm ^a  

^a TNO   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREMOPHOR; CYCLOSPORIN A; PREDNISOLONE; SOLVENT;

AGING; ANIMAL MODEL; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL;

EID: 0029874750     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0062     Document Type: Article

References (20)

1. Penn, I., Tumors of the immunocompromised patient. Annu. Rev. Med. 39, 63-73, 1988.
2. Penn, I., The changing pattern of posttransplant malignancies. Transplant. Proc. 23, 1101-1103, 1991.
3. Cockburn, I., Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune. Transplant. Proc. 19, 1804-1807, 1987.
4. Hanto, D. W., and Simmons, R. L., Lymphoproliferative diseases in immunosuppressed patients. In "Progress in Transplantation" (P. J. Morris and N. L. Tilney, Eds.), Vol. 1, pp. 186-208, Churchill-Livingstone, Edinburgh, 1984.
5. Joseph, G., Barker, R. L., Yuan, B., Martin, A., Medeiros, J., and Peiper, S. C., Posttransplant plasma cell dyscrasias. Cancer 74, 1959-1964, 1994.
6. Perkins, E. H., Peterson, W. J., Gottlieb, C. F., Halsall, M. K., Cacheiro, L. H., and Makinodan, T., The late effects of selected immunosuppressants on immunocompetence, disease incidence, and mean life-span. I. Humoral immuneactivity. Mech. Ageing Dev. 4, 231-240, 1975.
7. Peterson, W. J., Perkins, E. H., Goodman, S. A., Hori, Y., Halsall, M. K., and Makinodan, T., The late effects of selected immunosuppressants on immunocompetence, disease incidence, and mean life-span. II. Cell-mediated immuneactivity. Mech. Ageing Dev. 4, 241-250, 1975.
8. Peter, C. P., Perkins, E. H., Peterson, W. J., Walburg, H. E., and Makinodan, T., The late effects of selected immunosuppressants on immunocompetence, disease incidence, and mean life-span. III. Disease incidence and life expectancy. Mech. Ageing Dev. 4, 251-260, 1975.
9. Peest, D., Schaper, B., Nashan, B., Wonigeit, K., Raude, E., Pichlmayr, R., Haverich, A., and Deicher, H., High incidence of monoclonal immunoglobulins in patients after liver or heart transplantation. Transplantation 46, 389-395, 1988.
10. Radl, J., Valentijn, R. M., Haaijman, J. J., and Paul, L. C., Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin. Immunol. Immunopathol. 37, 98-102, 1985.
11. Radl, J., Monoclonal B-cell proliferative disorders and aging. In "Physiological Senescence and Its Postponement: Theoretical Approaches and Rational Interventions" (W. Pierpaoli and N. Fabris, Eds.), Ann. N.Y. Acad. Sci., Vol. 621, pp. 418-427, 1991.
12. Radl, J., Aging and proliferative homeostasis: Monoclonal gammopathies in mice and men. Lab. Anim. Sci. 42, 138-141, 1992.
13. Radl, J., The C57BL/KaLwRij mouse model in the studies of monoclonal gammapathies. In "Multiple Myeloma and Related Disorders" (F. Dammacco and B. Barlogie, Eds.), Series Challenges of Modern Medicine, Vol. 4, pp. 11-17, Ares-Serono Symposia Publications, Rome, 1994.
14. Van Zwieten, M. J., Zurcher, C., Solleveld, H. A., and Hollander, C. F., Pathology. In "Immunological Techniques Applied to Aging Research" (W. H. Adler and A. A. Nordin, Eds.), pp. 1-36, CRC, Boca Raton, 1981.
15. Nooij, F. J. M., Van der Sluijs-Gelling, A. J., and Radl, J., Development of aging-associated monoclonal gammapathies with antibody activity to the antigen used for immunization of young mice. Clin. Immunol. Immunopathol. 63, 110-114, 1992.
16. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., and Skipper, H. E., Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother. Rep. 50, 219-223, 1966.
17. Radl, J., Effects of aging on immunoglobulins. In "Immunological Techniques Applied to Aging Research" (W. H. Adler and A. A. Nordin, Eds.), pp. 121-139, CRC, Boca Raton, 1981.
18. Nooij, F. J. M., Van der Sluijs-Gelling, A. J., Jol-van der Zijde, C. M., Van Tol, M. J. D., Haas, H., and Radl, J., Immunoblotting techniques for, the detection of low level homogeneous immunoglobulin components in serum. J. Immunol. Methods 134, 273-281, 1990.
19. Au, W. W., Anwar, W., Paolini, M., Ramanujam, S., and Cantelli-Forti, G., Mechanism of clastogenic and co-clastogenic activity of cremophore with benzene in mice. Carcinogenesis 12, 53-57, 1991.
20. Fallskog, M-L., Frii, L., and Bergh, J., Is Cremophor EL, solvent for paclitaxel, cytotoxic? Lancet 324, 873, 1993.